July 17, 2012 -- SFL is delighted to announce that Shayesteh Fürst-Ladani, Managing Director of the
company, has received the Open University Business School’s Alumni Award Outstanding
Contribution to an Organisation 2012.
The Open University Business School Alumni Network nominated and elected individuals
that demonstrated best the application of learnings from their Open University MBA
training and achievement of outstanding results. This year’s awards were presented at a
lunch ceremony held at The Open University campus at Walton Hall, Milton Keynes, UK on
Friday 13 July.
Speaking at the ceremony, Professor Rebecca Taylor, Dean of The Open University Business
and Law Schools, commented that OU students are different: "Being 'open' does not mean
easy; we offer a rigorous education and qualifications that are recognised across the globe.
It means commitment and sheer hard graft on the part of our students. Our students and
alumni are special: determined, resilient and focused on success."
“I’m very honoured to receive this award,” commented Shayesteh. “I always wanted to
build up an innovative company and my time at the Open University was invaluable in
providing me with the necessary knowledge for doing so and encouraging me to become an
Shayesteh was nominated in recognition of her business achievements following the
completion of her MBA at the Open University. Since its founding in 2009, SFL has grown
rapidly and expanded its services in regulatory affairs, public affairs, legal services and
medical communications for international clients in the health care sector. She leads the
team at SFL and provides global strategic support for the development and approval of
healthcare products. Shayesteh has a comprehensive knowledge base and experience in
formulating global regulatory strategies for drugs, orphan drugs, drug & device combination
products, borderline products, medical devices, in vitro diagnostics and advanced therapy
Shayesteh is Chair of Combination Products Topic Group at EuropaBio and Medical Device
Working Group at EUCOPE. She has been member of the Program Committee of DIA
EuroMeeting for 2011, 2012 and 2013 leading the Theme Drugs, Devices, in vitro Diagnostics
and their Combinations. Shayesteh is also Chair of SIAC (Special Interest Area Community)
for Devices & Diagnostics at DIA.
Shayesteh held several management positions within the pharma, biotech and medical
device sectors before founding SFL. She was Head of Global Regulatory Affairs for Kuros
Biosurgery, Global Regulatory Leader at F. Hoffmann-La Roche, and Head of Regulatory
Affairs for Development Products at Baxter Bioscience, BioSurgery Unit. She received her
MSc in Microbiology from the University of Vienna, Austria, and an MBA from the Open
University Business School, Milton Keynes, UK.
About SFL Regulatory Affairs & Scientific Communication Ltd
SFL provides a holistic approach to lifecycle management of healthcare products from pre-
clinical studies and clinical trials through to registration and post-approval activities. The
company’s team of professionals have experience in Regulatory Affairs, Public Affairs, Legal
Services and Medical Communications. SFL supports its clients by offering personalized and
comprehensive services. When combined, these services provide an integral oversight
package for products from the bench to the marketplace at one consultancy.
For more information, please contact:
SFL Regulatory Affairs & Scientific Communication Ltd
Tel: +41 61 361 9443
Fax: +41 61 361 9442